Updated Jan 16, 2018

Default inno

Filling the gap

A low-cost, non-invasive test for visceral leishmaniasis

https://muhc.ca/research/dashboard

The innovation has no owner

CLAIM IT

Stage 2: Research & Development

Registered in Canada.

Focus Areas:

Health

HealthSEE LESS

Implemented In:

Nepal

NepalSEE LESS

1
Country Implemented In
Verified Funding
?

Innovation Description

Safe and simple, Dr. Cedric Yansouni's new approach to testing for visceral leishmaniasis in low-resource settings is a unique non-invasive test.
How does your innovation work?
Better tests are urgently needed for visceral leishmaniasis, which causes more deaths per year than any parasitic disease except malaria. Safe, simple and non-invasive, Dr. Cedric Yansouni's new approach to testing for visceral leishmaniasis in low-resource settings is a unique non-invasive test that (i) addresses key gaps in current diagnostic capabilities and (ii) has the potential to be scaled-up using an electricity-free platform.

Milestones

Date Unknown
Created
Date Unknown
New Country Implemented In
Nepal